Archives

by in
Entry Author Date Location
Atlas Leans on Amgen, Novartis to Build New Startups 05/16/13 Boston
Ra Pharmaceuticals Clinches Merck Deal for Up to $200 Million 04/01/13 Boston
Theraclone Secures $14M to Push Antibody Drug Programs 03/25/13 Seattle
Theraclone Sciences Receives $14,000,000 Series B Funding Round 03/25/13 Seattle
Theraclone Sciences Garners $14,000,000 Series B Financing 03/25/13 Seattle
Sutro Strikes Celgene Deal Worth Up to $500M 12/18/12 San Francisco
Ra Pharma Pours $8.6M Into Discovery Tech and New Rare-Disease Drug 05/23/12 Boston
Ra Pharmaceuticals Receives $8,600,000 Series A Financing Round 05/16/12 Boston
Sutro Biopharma Pulls in $16M for New Antibody Drugs 05/08/12 San Francisco
MiRagen Therapeutics Garners $20,000,000 Series B Funding Round 04/24/12 Boulder/Denver
Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy 12/22/11 Seattle
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
Theraclone Sciences Secures $10,600,000 Series B Round 09/08/11 Seattle
Ardelyx Nabs $30M To Develop Drug for Irritable Bowel Syndrome, and High Blood Pressure 08/31/11 San Francisco
Ardelyx Garners $30,000,000 Series B Funding 08/31/11 San Francisco
Oncofactor Garners $2,100,000 Series A Financing Round 05/25/11 Seattle
Gilead Buys Calistoga Pharma for $375M, Making Move Into Cancer Drugs 02/22/11 Seattle
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections 01/18/11 Seattle
Allozyne Passes First Clinical Trial, Dreams Big About a Once-Monthly Multiple Sclerosis Drug 01/10/11 Seattle
Accelerator Reaches Out to East Coast to Find Latest Startup, Acylin Therapeutics 12/01/10 Seattle
Sutro Biopharma Grabs $36.5M in Venture Deal to Make “Biobetters” 11/17/10 San Francisco
Sutro Biopharma Secures $36,500,000 Series C Round 11/17/10 San Francisco
Biotech DecImmune Grabs $1M from Astellas VC 09/27/10 Boston
DecImmune Therapeutics Lands $1,000,000 New Funding Round 09/27/10 Boston
Allozyne, After a Stealthy Year on a Slim Budget, Re-Emerges with MS Drug and Fat Pipeline 07/14/10 Seattle
Calistoga Pharmaceuticals Nabs $40M in Washington’s Biggest Venture Deal of 2010 06/30/10 Seattle
Calistoga Pharmaceuticals Garners $40,000,000 Series C Funding 06/30/10 Seattle
Theraclone Sciences CEO David Fanning Dies Suddenly 06/14/10 Seattle
Avvo Follows Amazon and Expedia, Ignition and General Catalyst Back Travel Startup, Gist Goes Networking, & More Seattle-Area Deals News 03/23/10 Seattle
Theraclone Raises $1.5M 03/19/10 Seattle
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Automatic's App Puts Your Smartphone in Charge of Your Car

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.